Total Payments
$648.71
2020 Payments
$105.01
Companies
22
Transactions
34
Medicare Patients
19,188
Medicare Billing
$974,205
Payment Breakdown by Category
Food & Beverage$648.71 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $648.71 | 34 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $102.73 | 5 | $0 (2020) |
| Eisai Inc. | $66.02 | 4 | $0 (2020) |
| Celgene Corporation | $55.86 | 3 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $46.35 | 2 | $0 (2020) |
| Daiichi Sankyo Inc. | $38.51 | 1 | $0 (2020) |
| Siemens Medical Solutions USA, Inc. | $31.33 | 2 | $0 (2019) |
| Ipsen Biopharmaceuticals, Inc | $30.73 | 2 | $0 (2019) |
| Abbott Laboratories | $30.55 | 1 | $0 (2017) |
| Amgen Inc. | $24.43 | 1 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.84 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $105.01 | 5 | Daiichi Sankyo Inc. ($38.51) |
| 2019 | $281.03 | 16 | EISAI INC. ($49.73) |
| 2018 | $189.51 | 10 | Celgene Corporation ($55.86) |
| 2017 | $73.16 | 3 | Abbott Laboratories ($30.55) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/20/2020 | Advanced Accelerator Applications | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: ONCOLOGY | ||||||
| 01/30/2020 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Oncology | ||||||
| 01/15/2020 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $16.29 | General |
| Category: Oncology | ||||||
| 01/09/2020 | Alexion Pharmaceuticals, Inc. | Ultomiris (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Immunology | ||||||
| 01/02/2020 | Daiichi Sankyo Inc. | Turalio (Drug) | Food and Beverage | In-kind items and services | $38.51 | General |
| Category: Oncology | ||||||
| 11/20/2019 | Siemens Medical Solutions USA, Inc. | MAGNETOM Sola (Device) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: MR - MRI | ||||||
| 11/05/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: NEPHROLOGY | ||||||
| 09/18/2019 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $21.35 | General |
| Category: Oncology | ||||||
| 08/29/2019 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Immunology | ||||||
| 07/29/2019 | Siemens Medical Solutions USA, Inc. | MAGNETOM Sola (Device) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: MR - MRI | ||||||
| 07/11/2019 | GENZYME CORPORATION | LIBTAYO (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: ONCOLOGY | ||||||
| 06/13/2019 | Ipsen Biopharmaceuticals, Inc | SOMATULINE DEPOT (Drug), ONIVYDE | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Oncology/Endocrinology | ||||||
| 04/25/2019 | West Therapeutics Development, LLC | Lazanda (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Opioid Agonist | ||||||
| 04/18/2019 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Oncology | ||||||
| 04/18/2019 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $20.84 | General |
| 04/04/2019 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: ONCOLOGY | ||||||
| 03/22/2019 | Array BioPharma Inc. | Braftovi (Drug), Mektovi | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Melanoma | ||||||
| 03/21/2019 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $11.15 | General |
| Category: Oncology | ||||||
| 02/20/2019 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Oncology | ||||||
| 02/07/2019 | Ipsen Biopharmaceuticals, Inc | SOMATULINE DEPOT (Drug), ONIVYDE | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Oncology/Endocrinology | ||||||
| 01/23/2019 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $17.23 | General |
| Category: Oncology | ||||||
| 12/20/2018 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: BioOncology | ||||||
| 12/12/2018 | EMD Serono, Inc. | Bavencio (Biological) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Oncology | ||||||
| 07/12/2018 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Oncology | ||||||
| 06/21/2018 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Hematology / Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 60 | 5,112 | 20,892 | $1.9M | $255,265 |
| 2022 | 59 | 4,868 | 16,548 | $1.8M | $263,868 |
| 2021 | 58 | 4,361 | 20,119 | $1.7M | $242,039 |
| 2020 | 60 | 4,847 | 15,593 | $1.3M | $213,033 |
Total Patients
19,188
Total Services
73,152
Medicare Billing
$974,205
Procedure Codes
322
All Medicare Procedures & Services
322 procedure records from CMS Medicare Utilization — Page 1 of 13
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 85 | 85 | $160,132 | $23,527 | 14.7% |
| 77067 | Screening mammography | Office | 2023 | 145 | 145 | $108,446 | $21,137 | 19.5% |
| 73721 | Mri scan of leg joint without contrast | Office | 2023 | 106 | 107 | $138,386 | $18,650 | 13.5% |
| 73221 | Mri scan of arm joint without contrast | Office | 2023 | 80 | 80 | $104,928 | $14,470 | 13.8% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 66 | 66 | $71,920 | $10,167 | 14.1% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 98 | 98 | $78,042 | $9,759 | 12.5% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 140 | 140 | $41,524 | $8,128 | 19.6% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 238 | 262 | $59,267 | $8,005 | 13.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 379 | 384 | $63,275 | $7,967 | 12.6% |
| 73564 | X-ray of knee, 4 or more views | Office | 2023 | 187 | 188 | $81,969 | $7,265 | 8.9% |
| 77073 | X-ray for bone length assessment | Office | 2023 | 180 | 182 | $47,802 | $6,844 | 14.3% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 180 | 181 | $48,455 | $6,279 | 13.0% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 232 | 245 | $54,623 | $6,229 | 11.4% |
| 72082 | X-ray of entire middle and lower spine, 2-3 views | Office | 2023 | 86 | 89 | $36,677 | $5,003 | 13.6% |
| 73718 | Mri scan of leg without contrast | Office | 2023 | 25 | 25 | $34,448 | $4,664 | 13.5% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 40 | 40 | $40,296 | $4,583 | 11.4% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 162 | 163 | $32,480 | $4,519 | 13.9% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 168 | 172 | $35,975 | $4,482 | 12.5% |
| 73200 | Ct scan of arm without contrast | Office | 2023 | 35 | 35 | $33,315 | $4,413 | 13.2% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 14 | 14 | $29,549 | $3,929 | 13.3% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2023 | 98 | 98 | $27,052 | $3,781 | 14.0% |
| 76881 | Complete ultrasound scan of joint | Facility | 2023 | 108 | 109 | $19,275 | $3,725 | 19.3% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Facility | 2023 | 56 | 57 | $25,439 | $3,713 | 14.6% |
| 73110 | X-ray of wrist, minimum of 3 views | Office | 2023 | 111 | 119 | $30,120 | $3,594 | 11.9% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 121 | 127 | $31,933 | $3,338 | 10.5% |
About Matthew Minn
Matthew Minn is a Diagnostic Radiology healthcare provider based in La Jolla, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2009. The National Provider Identifier (NPI) number assigned to this provider is 1164666954.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Matthew Minn has received a total of $648.71 in payments from pharmaceutical and medical device companies, with $105.01 received in 2020. These payments were reported across 34 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($648.71).
As a Medicare-enrolled provider, Minn has provided services to 19,188 Medicare beneficiaries, totaling 73,152 services with total Medicare billing of $974,205. Data is available for 4 years (2020–2023), covering 322 distinct procedure/service records.
Ad
Practice Information
- Specialty Diagnostic Radiology
- Other Specialties Student in an Organized Health Care Education/Training Program, Diagnostic Radiology
- Location La Jolla, CA
- Active Since 04/24/2009
- Last Updated 07/21/2022
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1164666954
Products in Payments
- Lenvima (Drug) $66.02
- Nexavar (Drug) $44.74
- Turalio (Drug) $38.51
- Abraxane (Drug) $35.02
- MAGNETOM Sola (Device) $31.33
- SOMATULINE DEPOT (Drug) $30.73
- CRT-Ds (Device) $30.55
- Blincyto (Biological) $24.43
- ULTOMIRIS (Drug) $23.59
- Eovist (Drug) $23.06
- Ultomiris (Drug) $22.76
- Revlimid (Drug) $20.84
- SAMSCA (Drug) $20.54
- Stivarga (Drug) $20.14
- Bavencio (Biological) $19.70
- IMFINZI (Drug) $19.55
- Nerlynx (Drug) $18.90
- TECENTRIQ (Biological) $17.95
- OPDIVO (Biological) $17.65
- FOUNDATIONONE (Device) $16.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in La Jolla
Dr. Nikunj Patel, M.d, M.D
Diagnostic Radiology — Payments: $39,681
Diagnostic Radiology $39,681
Dr. Maurice Zissen, M.d, M.D
Diagnostic Radiology — Payments: $28,131
Diagnostic Radiology $28,131
Dr. Mohsin Saeed, M.d, M.D
Diagnostic Radiology — Payments: $13,655
Diagnostic Radiology $13,655
Dr. Brandon Grusd, M.d., J.d, M.D., J.D
Diagnostic Radiology — Payments: $11,073
Diagnostic Radiology $11,073
Trevor Nelson, M.d, M.D
Diagnostic Radiology — Payments: $7,909
Diagnostic Radiology $7,909
Dr. Harold Pimenta, M.d, M.D
Diagnostic Radiology — Payments: $5,018
Diagnostic Radiology $5,018